Sarah Emond
President and CEO of the Institute for Clinical and Economic Review (ICER), expert in health technology assessment and drug value assessment who explains how other countries set drug prices.
Best podcasts with Sarah Emond
Ranked by the Snipd community
Oct 16, 2025 • 37min
Will TrumpRx actually lower drug prices?
Joined by Dr. Jerry Avorn, a Harvard professor and drug policy expert, and Sarah Emond, CEO of ICER and a health technology assessment authority, the discussion dives deep into the new TrumpRx initiative. They analyze how U.S. drug prices soar due to lack of government negotiation. The duo shares insights on the implications of Pfizer’s Medicaid commitments and whether anyone benefits from these discounts. Emond explains how other countries, like the UK, manage to set lower prices, suggesting a need for independent value assessments in the U.S.
Nov 22, 2023 • 37min
Cell and Gene Therapy: Tapping into the Potential of Curative Treatment
In this conversation, Sarah Emond, the President-Elect of ICER, dives into the transformative landscape of cell and gene therapies. She discusses how these innovations tackle the root causes of diseases like hemophilia and muscular dystrophy, offering hope for previously terminal conditions. Emond highlights challenges in manufacturing and accessibility, and advocates for innovative financing models, such as outcomes-based contracts, to make these life-altering treatments more accessible. The future looks bright, but equitable access remains crucial.
